Company profile

Abbott

Abbott has 1 AI-enabled medical device on the FDA list. The first decision was on September 17, 2025 and the most recent on September 17, 2025 (Assert-IQ (DM5000); Assert-IQ (DM5300); Assert-IQ (DM5500); Merlin.net (MN7000)). Its most common review panel is Cardiovascular (1 device).

1AI devices
2025First decision
2025Latest decision
1Specialties

Timeline

  1. Assert-IQ (DM5000); Assert-IQ (DM5300); Assert-IQ (DM5500); Merlin.net (MN7000) · Cardiovascular · MXD